Presenting data at the cancer immunotherapy SITC conference

On October 30, 2019 MonTa Biosciences reported that is attending the cancer immunotherapy SITC (Free SITC Whitepaper) conference in Washington DC to present data on our lead candidate MBS8 (Press release, MonTa Biosciences, OCT 30, 2019, View Source [SID1234618628]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!